Abstract:The poor prognosis of cancer and other diseases has often been linked to challenges pertaining to drug accessibility and delivery. To combat these challenges, nanotechnology has witnessed decades of intensive research, resulting in the development of innovative nanoscale strategies for improving therapies and minimizing the side effects of existing drugs. Notably, multiple nanocarriers have obtained clinical approval as proficient drug delivery systems. Metal-organic frameworks (MOFs) have emerged as an interesting paradigm owing to their tuneable porosity, structural diversity, and ease of external surface functionalization. Compared to other drug delivery systems, state-of-the-art MOFs can encapsulate up to 50 times higher quantities of drugs per unit of mass while showing very long release times. Nevertheless, for their translation into clinical applications, concerns regarding MOF biocompatibility necessitate comprehensive mitigation. Unfortunately, experiments are resource and time-intensive, while modeling approaches fail to capture the behavior of MOFs in intricate biological systems. To overcome these barriers, we review here recent advances on biocompatibility and propose a novel computational pipeline guided by machine learning (ML). This is designed to expedite the assessment of potential MOF toxicity based on the chemical properties of their precursors. Interpretable ML models were built on a database of over 35,000 organic molecules, predicting the potential toxicity of MOF linkers with 83% accuracy. Additionally, we established a comprehensive database cataloging the toxicity of MOF metallic centers. Leveraging these, we have screened the Cambridge Structural Database (CSD) containing 86,000 non-disordered MOFs, identifying existing and future promising candidates with minimal toxicity profiles for drug delivery applications. Beyond high-throughput screening, the developed models shed light on the chemical landscape associated with high biocompatibility precursor molecules, enabling the derivation of guidelines for the rational design of biocompatible MOFs. This framework thus expedites the identification of biocompatible materials, while facilitating deeper insights into their underlying chemistry. The protocols developed here will be easily transferred to other systems, accelerating associated research timescales.

Metal-Organic Frameworks for Cisplatin Delivery to Cancer Cells: A Molecular Dynamics Simulation

Dual-Stimulus-Triggered Programmable Drug Release and Luminescent Ratiometric Ph Sensing from Chemically Stable Biocompatible Zinc Metal-Organic Framework.

Decoration of Cisplatin on 2D Metal-Organic Frameworks for Enhanced Anticancer Effects through Highly Increased Reactive Oxygen Species Generation.

Therapeutic Application of Metal–Organic Frameworks Composed of Copper, Cobalt, and Zinc: Their Anticancer Activity and Mechanism

An integrated experimental and simulation study on the loading of cytarabine in a biocompatible zinc imidazole metal–organic framework

A molecular dynamic simulation study of anticancer agents and UiO-66 as a carrier in drug delivery systems

Comprehensive Computational Investigation of the Porphyrin-Based COF as a Nanocarrier for Delivering Anti-Cancer Drugs: A Combined MD Simulation and DFT Calculation

Biodegradable Metal–Organic‐Framework‐Gated Organosilica for Tumor‐Microenvironment‐Unlocked Glutathione‐Depletion‐Enhanced Synergistic Therapy

Investigating the Size Effect of Metal-Organic Frameworks in Drug Delivery and Anticancer Properties

Nanoscale aggregation of doxorubicin-short peptide conjugates for enzyme-responsive delivery with various MOF carriers: In-silico steps towards smart cancer chemotherapy

Metal-Organic Frameworks (MOFs)-Based Nanomaterials for Drug Delivery

Innovative Metal-Organic Frameworks for Targeted Oral Cancer Therapy: A Review

Design of metal-organic framework composites in anti-cancer therapies

Co-Delivery of VEGF siRNA and THPP via Metal-Organic Framework Reverses Cisplatin-Resistant Non-Small Cell Lung Cancer and Inhibits Metastasis through a MUC4 Regulating Mechanism

Metal–organic frameworks as nanoplatforms for combination therapy in cancer treatment

Guiding the rational design of biocompatible metal-organic frameworks for drug delivery using machine learning

Abstract C027: Nanoscale-metal organic frameworks as drug delivery vehicles for novel hepatocellular carcinoma therapy

MOFs for next-generation cancer therapeutics through a biophysical approach—a review

Adenosine/β-Cyclodextrin-Based Metal–Organic Frameworks as a Potential Material for Cancer Therapy

Organoid-Based Assessment of Metal-Organic Framework (MOF) Nanomedicines for Ex Vivo Cancer Therapy

Copper-Based Metal–Organic Framework Overcomes Cancer Chemoresistance through Systemically Disrupting Dynamically Balanced Cellular Redox Homeostasis